Control of the Physical Form of Salmeterol Xinafoate-Reference-Cited by-同舟云学术

Control of the Physical Form of Salmeterol Xinafoate

Published:1999-08-12 Issue:5 Volume:3 Page:370-376
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Beach Steve¹,Latham David¹,Sidgwick Colin¹,Hanna Mazen¹,York Peter¹

Affiliation:

1. Glaxo-Wellcome Research and Development, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK, Bradford Particle Design, 49 Campus Road, Listerhills Science Park, Bradford, BD7 1HR, UK, and Drug Delivery Group, School of Pharmacy, University of Bradford, Bradford, BD7 1DP, UK

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/op990160z

Reference13 articles.

1. Experimental determination of the regional deposition of aerosol particles in the human respiratory tract

2. Dobson, B.; Rothwell, E.Powder Technology1969/70,3, 213.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies;Acta Pharmaceutica Sinica B;2021-08

2. Dry Powder for Pulmonary Delivery: A Comprehensive Review;Pharmaceutics;2020-12-28

3. Approaches to Solid-Form Screening;Polymorphism in the Pharmaceutical Industry;2018-12-21

4. Crystallographic Structure, Intermolecular Packing Energetics, Crystal Morphology and Surface Chemistry of Salmeterol Xinafoate (Form I);Journal of Pharmaceutical Sciences;2017-03

5. Polymorphism control of p-aminobenzoic acid by isothermal anti-solvent crystallization;Journal of Crystal Growth;2016-11